Ingrid De Meester

12.7k citations

219 papers · 10.6k indexed · 2 hit papers · h-index 56

Impact in

Oncology top 0.2%
- Peptidase Inhibition and Analysis
- Chemokine receptors and signaling
Biological Psychiatry top 0.5%

Papers in

Cellular and Molecular Neuroscience 120
- Neuropeptides and Animal Physiology 119
Oncology 176
- Peptidase Inhibition and Analysis 169
- Chemokine receptors and signaling 16

Co-authors: Simon Scharpé Anne‐Marie Lambeir Christine Durinx Jo Van Damme Koen Augustyns Greet Vanhoof Paul Proost Pieter Van der Veken
Journals: Journal of Medicinal Chemistry (15 papers)Biochemical Pharmacology (8 papers)Advances in experimental medicine and biology (7 papers)Clinica Chimica Acta (7 papers)European Journal of Medicinal Chemistry (6 papers)
Partner nations: Belgium Germany Switzerland

In The Last Decade

Ingrid De Meester

217 papers receiving 10.3k citations

Hit Papers

align trajectories log scale

Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV 2003 · 809 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2003 Critical Reviews in Clinical Laboratory Sciences
1998 Cytokine

Peers

Countries citing papers authored by Ingrid De Meester

Since Specialization

Citations

This map shows the geographic impact of Ingrid De Meester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid De Meester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid De Meester more than expected).

Fields of papers citing papers by Ingrid De Meester

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid De Meester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid De Meester. The network helps show where Ingrid De Meester may publish in the future.

Co-authors

The 25 scholars most cited alongside Ingrid De Meester, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ingrid De Meester Line = papers co-authored together Ingrid De Meester links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Human Transmembrane Serine Protease 2 (TMPRSS2) on Human Seminal Fluid Extracellular Vesicles Is Proteolytically Active Journal of Extracellular Vesicles ·李发新, Duane S. Cooley, Pascale Berckmans, Xue Jing-fan, Koen Augustyns, Isabel Pintelon, Maya Berg, Pieter Van Wielendaele, Anne‐Marie Lambeir, Yann G.‐J. Sterckx, Inge Nelissen, Ingrid De Meester	2025	1
2	Active site-directed probes targeting dipeptidyl peptidases 8 and 9 European Journal of Medicinal Chemistry ·Lee Walk, (unknown), Valeria García-Ramos, Samira Cheraitia, Sofie Thys, М. Грабовский, 李发新, Groenemeyer Gs, 任佳希, Koen Augustyns, Pieter Van Wielendaele, Isabel Pintelon, Ingrid De Meester, (unknown), (unknown)	2024	4
3	Next generation fibroblast activation protein (FAP) targeting PET tracers - The tetrazine ligation allows an easy and convenient way to 18F-labeled (4-quinolinoyl)glycyl-2-cyanopyrrolidines European Journal of Medicinal Chemistry ·Christian B. M. Poulie, Vladimir Shalgunov, Filipe Elvas, М. Грабовский, Euy Sung Moon, Umberto Maria Battisti, Valeria García-Ramos, Ingrid De Meester, Frank Rösch, Pieter Van der Veken, Matthias M. Herth	2023	10
4	The Chemokine-Based Peptide, CXCL9(74-103), Inhibits Angiogenesis by Blocking Heparan Sulfate Proteoglycan-Mediated Signaling of Multiple Endothelial Growth Factors Cancers ·Vladimir Vdovenko, Ahmet Serkan Akharman, Nele Berghmans, Melissa García‐Caballero, 秀人神先, Noëmie Pörtner, Vincent Vanheule, Anne Benham, Mohammad Mairaj Siddiquei, Ahmed M. Abu El‐Asrar, Peter Carmeliet, Pieter Van Wielendaele, Ingrid De Meester, Jo Van Damme, Paul Proost, Sofie Struyf	2021	15
5	Local Colonic Administration of a Serine Protease Inhibitor Improves Post-Inflammatory Visceral Hypersensitivity in Rats Pharmaceutics ·Nikita Hanning, Duane S. Cooley, Hannah Ceuleers, Tim Boogaerts, Maya Berg, Annemieke Smet, Heiko U. De Schepper, Jurgen Joossens, Alexander L.N. van Nuijs, Joris G. De Man, Koen Augustyns, Ingrid De Meester, Benedicte Y. De Winter	2021	12
6	Newly developed serine protease inhibitors decrease visceral hypersensitivity in a post‐inflammatory rat model for irritable bowel syndrome British Journal of Pharmacology ·Hannah Ceuleers, Nikita Hanning, 刘博涵, Jean-Michel Gasser, Jurgen Joossens, Pieter Van der Veken, Sven Francque, Duane S. Cooley, Anne‐Marie Lambeir, Joris G. De Man, Jean‐Pierre Timmermans, Koen Augustyns, Ingrid De Meester, Benedicte Y. De Winter	2018	36
7	Peroxynitrite Exposure of CXCL12 Impairs Monocyte, Lymphocyte and Endothelial Cell Chemotaxis, Lymphocyte Extravasation in vivo and Anti-HIV-1 Activity Frontiers in Immunology ·Rik Janssens, Daiane Boff, Pieter Ruytinx, Anneleen Mortier, Vincent Vanheule, Olav Larsen, 梁海松, Mette M. Rosenkilde, Sam Noppen, Sandra Liekens, Dominique Schols, Ingrid De Meester, Ghislain Opdenakker, Sofie Struyf, Mauro Martins Teixeira, Flávio A. Amaral, Paul Proost	2018	6
8	Regulation of intestinal permeability: The role of proteases World Journal of Gastroenterology ·Vickie Spayth, Hannah Ceuleers, H. Auda, Philippe A Tirman, Jurgen Joossens, Koen Augustyns, Anne‐Marie Lambeir, Ingrid De Meester, Joris G. De Man, Benedicte Y. De Winter	2017	139
9	Circulating Stromal Cell-Derived Factor 1α Levels in Heart Failure: A Matter of Proper Sampling PLoS ONE ·Lesley Baerts, Yannick Waumans, Inger Brandt, Wolfgang Jungraithmayr, Pieter Van der Veken, Marc Vanderheyden, Ingrid De Meester	2015	16
10	Effect of Heart Failure on Dipeptidyl Peptidase IV Activity in Plasma of Dogs Journal of Veterinary Internal Medicine ·Nelson Gomez, Veerle Matheeussen, v. Tobold, Benjamin K. Gutierrez, Anne‐Christine Merveille, Raissa Anugrah Putri, C. Michaux, Cécile Clercx, Ingrid De Meester, Kathleen Mc Entee	2012	15
11	Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivity Bioorganic & Medicinal Chemistry Letters ·O.V. Ryabtsova, Koen Jansen, V.A. Chuhin, Jurgen Joossens, Jonathan D. Cheng, Anne‐Marie Lambeir, Ingrid De Meester, Koen Augustyns, Pieter Van der Veken	2012	47
12	Dipeptidyl Peptidase IV Inhibition Improves Cardiorenal Function in Overpacing-Induced Heart Failure European Journal of Heart Failure ·Nelson Gomez, M. Artuso, Veerle Matheeussen, 公敏有間, Maryam Mahmoudabady, Myrielle Mathieu, Lesley Baerts, Aaron Peace, Pascale Lybaert, Simon Scharpé, Ingrid De Meester, Jozef Bartúnek, Marc Vanderheyden, Kathleen Mc Entee	2011	91
13	Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries Biological Chemistry ·Veerle Matheeussen, Lesley Baerts, Guido R.Y. De Meyer, Gilles W. De Keulenaer, Pieter Van der Veken, Koen Augustyns, Véronique Dubois, Simon Scharpé, Ingrid De Meester	2011	59
14	Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 2: Isoindoline containing inhibitors Bioorganic & Medicinal Chemistry Letters ·V.A. Chuhin, Pieter Van der Veken, Véronique Dubois, Gerd Pleyer, Anne‐Marie Lambeir, Xin Chen, Achiel Haemers, Simon Scharpé, Ingrid De Meester, Koen Augustyns	2008	62
15	A kinetic study of glucagon-like peptide-1 and glucagon-like peptide-2 truncation by dipeptidyl peptidase IV, in vitro Biochemical Pharmacology ·Anne‐Marie Lambeir, Paul Proost, Simon Scharpé, Ingrid De Meester	2002	28
16	THE EFFECTS OF PSYCHOLOGICAL STRESS ON HUMANS: INCREASED PRODUCTION OF PRO-INFLAMMATORY CYTOKINES AND Th1-LIKE RESPONSE IN STRESS-INDUCED ANXIETY Cytokine ·Michaël Maes, Cai Song, Aihua Lin, Raf De Jongh, Claude Saunier, Günter Kenis, Eugène Bosmans, Ingrid De Meester, Ina Benoy, Hugo Neels, Paul Demedts, Aleksandar Janča, Simon Scharpé, R.S. Smith Hit paper breakdown →	1998	632
17	Amino-terminal Truncation of Chemokines by CD26/Dipeptidyl-peptidase IV Journal of Biological Chemistry ·Paul Proost, Ingrid De Meester, Dominique Schols, Sofie Struyf, Anne‐Marie Lambeir, Anja Wuyts, Ghislain Opdenakker, Erik De Clercq, Simon Scharpé, Jo Van Damme	1998	226
18	Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs Acta Psychiatrica Scandinavica ·Michaël Maes, Ingrid De Meester, Simon Scharpé, Roger Desnyder, Rakesh Ranjan, Herbert Y. Meltzer	1996	49
19	Disturbances in dexamethasone suppression test and lower availability of Ł-tryptophan and tyrosine in early puerperium and in women under contraceptive therapy Journal of Psychosomatic Research ·Michaël Maes, Madelaine Andersson, Christiaan Schotte, L. Delbeke, Yves Jacquemyn, Robert Verkerk, Ingrid De Meester, Simon Scharpé	1992	39
20	Kininase activity in human platelets: Cleavage of the Arg1-Pro2 bond of bradykinin by aminopeptidase P Biochemical Pharmacology ·Greet Vanhoof, Ingrid De Meester, Filip Goossens, Dirk Hendriks, Simon Scharpé, Arieh Yaron	1992	29

About Ingrid De Meester

Ingrid De Meester is a scholar working on Cellular and Molecular Neuroscience, Oncology, Endocrinology, Diabetes and Metabolism, Biological Psychiatry and Physiology, having authored 219 papers that have together received 10.6k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (169 papers), Neuropeptides and Animal Physiology (119 papers), Diabetes Treatment and Management (46 papers), Signaling Pathways in Disease (23 papers), Protease and Inhibitor Mechanisms (21 papers), Chemokine receptors and signaling (16 papers), Cardiac Structural Anomalies and Repair (15 papers) and Glycosylation and Glycoproteins Research (10 papers). The work is most often cited by research in Oncology (6.1k citations), Biological Psychiatry (475 citations), Cellular and Molecular Neuroscience (3.3k citations), Endocrinology, Diabetes and Metabolism (2.3k citations) and Behavioral Neuroscience (478 citations). Ingrid De Meester has collaborated with scholars based in Belgium, Germany and Switzerland. Frequent co-authors include Simon Scharpé, Anne‐Marie Lambeir, Christine Durinx, Simon Scharpé, Jo Van Damme, Koen Augustyns, Greet Vanhoof, Paul Proost, Pieter Van der Veken and Sofie Struyf. Their work appears in journals such as Journal of Medicinal Chemistry, Biochemical Pharmacology, Advances in experimental medicine and biology, Clinica Chimica Acta and European Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact